|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����Ī˾ |
|
�������Ƽ� |
| ��������������� | |
|
÷�������� |
|
��־ǿ��У |
| PubMed | |
|
Article by |
|
Article by |
����Ī˾��Ƥ���Ƶ�Ӧ�ý�չ
÷��������, ��־ǿ��У
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���
����Ī˾��һ��ǿЧ�������Ƽ�,���û����뻷����A����,����Ԥ������������ֲ�����췴Ӧ�Լ����������Լ������뻷����A��ͬ����,����Ī˾�ɾֲ��������ƶ���Ƥ����,Ӧ��ǰ��������
2 Ruzicka T, Assmann T, Homey B. Tacrolimus:the drug for the turn of the millennium? Arch Dermatol,1999, 135(5):574-580.
3 Funk JO, Maibach HI. Horizons in pharmacologic intervention in allergic contact dermat it is. J Am Acad Dermatol,1994, 31(6):999-1014.
4 O ckenfels HM,Nussbaum G,Schneck B, et al. The effect of cyclosporin A and FK506 on the cAMP cont ent in psoriatic keratinocytes. Skin Pharmacol, 1996, 9:281-288.
5 Lauerma AI, Surber C, M aibach HI. Absorption of topical tacrolimus(FK 506) in vitrot hrough human skin:comparison with cyclosporin A.Skin Pharmacol,1997, 10(5-6):230-234.
6 Alaiti S, Kang S, Fiedler VC, et al. Tacrolimus (FK506) ointment for atopic dermatitis:a phase I st udy in adults and childen. J Am Acad Dermatol, 1998, 38(1):69-76.
7 Jegasothy BV,A ckerman CW, Todo S, et al. Tacrolimusa new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol, 1992, 128(6):781-785.
8 The European FK506 Multicentre Psoriasis Study Group. Syst emictacrolimus is effective for t he treatment of psoriasis in a doubleblind,placebo-controlled study. Arch Dermatol, 1996, 132(4):419-423.
9 Sakane T, Mochizuki M, Inaba G,et al. A phaseòstudy of FK 506(tacrolimus) on refractory uveitis associated with Behcet.sdisease and allied conditions. Ryumachi, 1995, 35(5):802-813.
10 Koga T, Yano T, Ichikawa Y,et al. Pulmonary infiltrat es recovered by FK 506 in a patient with Behcetcs disease. Chest,1993, 104(1):309-311.
11 Ishioka M,Ohno S, Nakamura S, et al. FK506 treatment of noninfect iousuveitis. Am J Ophthalmol,1994, 118:723-729.
12 Abu-Elmagd K, Jegasothy BV, Ackerman CD, et al. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc,1991, 23(6):3328-3329.
13 Sandborn WJ. Preliminary report on the use of oraltacrolimus in the treatment of compli cated proximal small bowel and fist ulizing Crohns disease.Am J Gast roenterol, 1997, 92(5):876-879.
14 Weichert G, Sauder DN. Efficacy of tacrolimus in idiopathic treatment resist ant pyoderma gangrenosum. J Am Acad Dermatol, 1998, 39(4 Pt 1):648-650.
15 Boyd AS. New and emerging therapies for lichenoid dermatoses. Dermatol Clin, 2000, 18(1):21-29.
16 Yocum DE. Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clin North Am, 1996, 22(1):133-154.
17 Aoyama H, Tabat a N,Tanaka M,et al. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK-506 ointment. Br J Dermatol, 1995, 133(3):494-496.
18 Ruzicka T, Bieber T, Schopf E, et al. A short termtrial of tacrolimus ointment for atopic dermatitis. N Engl J Med, 1997, 337(12):816-821.
19 Boguniewicz M,Fiedler VC, Raimer S, et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol, 1998, 102(4 Pt 1):637-644.
20 Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis. Arch Dermatol, 1998, 134(9):1101-1102.
21 Remitz A, Reitamo S, Erkko P, et al. Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol, 1999, 141(1):103-107.
22 Yamamoto S, Jiang H, Kato R. Stimulation of hair growth by topical application of FK506, a potent immuno suppressiveagent. J Invest Dermatol ,1994, 102(2):160-164.
23 Thiers BH. Topicaltacrol imus:treatment failure in a pat ient with alopecia areata. Arch Dermatol,2000, 136(1):124.
24 Schuppe HC, Homey B, Assmann T, et al. Topical tacrolimus for pyoderma gangrenosum. Lancet,1998, 351:832.
25 Reich K,Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol, 1998, 139(4):755-757.
26 Richter-Hintz D, Schuppe HC, Homey B, et al. Topical tacrolimus is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol ,2000, 42(2 Pt 1):304-305.
27 Suga Y,Tsuboi R, Hashimoto Y,et al. A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus. J Am Acad Dermatol,2000, 42(3):520-522.
28 Reitamo S, Rissanen J, Remitz A, et al. Tacrolimus ointment does not affect collagen synthesis:results of a single-center randomized trial. J Invest Dermatol, 1998, 111(3):396-398